These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 20816272)

  • 1. Management of voltage-gated potassium channel antibody disorders.
    Merchut MP
    Neurol Clin; 2010 Nov; 28(4):941-59. PubMed ID: 20816272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Anti-VGKC antibody-associated limbic encephalitis/Morvan syndrome].
    Misawa T; Mizusawa H
    Brain Nerve; 2010 Apr; 62(4):339-45. PubMed ID: 20420173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immune-mediated neuromyotonia (Isaacs' syndrome)--clinical aspects and pathomechanism].
    Arimura K; Watanabe O
    Brain Nerve; 2010 Apr; 62(4):401-10. PubMed ID: 20420181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Limbic encephalitis with severe sleep disorder associated with voltage-gated potassium channels (VGKCs) antibodies].
    Montiel P; Sellal F; Clerc C; Richard P; Bataillard M
    Rev Neurol (Paris); 2008 Feb; 164(2):181-4. PubMed ID: 18358878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuromyotonia and limbic encephalitis sera target mature Shaker-type K+ channels: subunit specificity correlates with clinical manifestations.
    Kleopa KA; Elman LB; Lang B; Vincent A; Scherer SS
    Brain; 2006 Jun; 129(Pt 6):1570-84. PubMed ID: 16613892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis.
    Vincent A; Buckley C; Schott JM; Baker I; Dewar BK; Detert N; Clover L; Parkinson A; Bien CG; Omer S; Lang B; Rossor MN; Palace J
    Brain; 2004 Mar; 127(Pt 3):701-12. PubMed ID: 14960497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Chinese female Morvan patient with LGI1 and CASPR2 antibodies: a case report.
    Zhang L; Lu Q; Guan HZ; Mei JH; Ren HT; Liu MS; Peng B; Cui LY
    BMC Neurol; 2016 Mar; 16():37. PubMed ID: 26983964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of acute autoimmune limbic encephalitis with negative VGKC and NMDAR antibodies.
    Modoni A; Masciullo M; Spinelli P; Marra C; Tartaglione T; Andreetta F; Tonali P; Silvestri G
    Cogn Behav Neurol; 2009 Mar; 22(1):63-6. PubMed ID: 19372772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Current Perspective on Voltage-gated Potassium Channel Complex Antibody Associated Diseases].
    Watanabe O
    Brain Nerve; 2018 Apr; 70(4):315-328. PubMed ID: 29632280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Isaacs's syndrome and associated diseases].
    Watanabe O
    Rinsho Shinkeigaku; 2013; 53(11):1067-70. PubMed ID: 24291881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous muscle activity, Morvan's syndrome and limbic encephalitis: ionic or non ionic disorders?
    Serratrice G; Serratrice J
    Acta Myol; 2011 Jun; 30(1):32-3. PubMed ID: 21842591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Voltage-gated potassium channel antibodies associated limbic encephalitis in a patient with invasive thymoma.
    Ohshita T; Kawakami H; Maruyama H; Kohriyama T; Arimura K; Matsumoto M
    J Neurol Sci; 2006 Dec; 250(1-2):167-9. PubMed ID: 17028029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of Isaacs' syndrome following complete recovery of voltage-gated potassium channel antibody-associated limbic encephalitis.
    Takahashi H; Mori M; Sekiguchi Y; Misawa S; Sawai S; Hattori T; Kuwabara S
    J Neurol Sci; 2008 Dec; 275(1-2):185-7. PubMed ID: 18801496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia.
    Irani SR; Alexander S; Waters P; Kleopa KA; Pettingill P; Zuliani L; Peles E; Buckley C; Lang B; Vincent A
    Brain; 2010 Sep; 133(9):2734-48. PubMed ID: 20663977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potassium channel antibody-associated encephalitis with hypothalamic lesions and intestinal pseudo-obstruction.
    Sekiguchi Y; Takahashi H; Mori M; Ito S; Shimada H; Hattori T; Kuwabara S
    J Neurol Sci; 2008 Jun; 269(1-2):176-9. PubMed ID: 18378260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma exchange for anti GAD associated non paraneoplastic limbic encephalitis.
    Mazzi G; Roia DD; Cruciatti B; Matà S; Catapano R
    Transfus Apher Sci; 2008 Dec; 39(3):229-33. PubMed ID: 18955013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis.
    Malter MP; Helmstaedter C; Urbach H; Vincent A; Bien CG
    Ann Neurol; 2010 Apr; 67(4):470-8. PubMed ID: 20437582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myokymia, neuromyotonia, dermatomyositis, and voltage-gated K+ channel antibodies.
    Oh SJ; Alapati A; Claussen GC; Vernino S
    Muscle Nerve; 2003 Jun; 27(6):757-60. PubMed ID: 12766989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morvan syndrome: a case report and review of the literature.
    Abou-Zeid E; Boursoulian LJ; Metzer WS; Gundogdu B
    J Clin Neuromuscul Dis; 2012 Jun; 13(4):214-27. PubMed ID: 22622167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antibodies directed to voltage-gated potassium channels in sera from acquired neuromyotonia and related disorders].
    Arimura K
    Rinsho Shinkeigaku; 1999 Dec; 39(12):1235-6. PubMed ID: 10791086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.